This opportunity funds first-in-human or early-stage clinical studies of innovative recording and stimulating devices targeting central nervous system disorders. It promotes partnerships between clinical investigators and device manufacturers to facilitate clinical research, reduce barriers, and leverage existing safety data. Studies may involve non-invasive or implantable devices requiring FDA approval and are managed through a milestone-driven NIH program.
Eligible applicants include a wide range of entities such as state, county, city, and tribal governments, public and private institutions of higher education, nonprofits, for-profit organizations including small businesses, federal agencies, U.S. territories, and foreign institutions. Specific eligi
